The brilliance of putting the main part of the process inside of a sealed container is that the cartridge can become the focus of manipulation and action ultimately. At this point, they are still operating souped up Flaskworks lab equipment, or at least that is the appearance at this stage. It’s exciting, but the potential for future innovation of the process is much more exciting to me. The core of the patent is, in fact about the use of the cartridge, the disposables and the self-contained processing. The work is primarily done in the cartridge, and the machine services that process. So the rest of the machinery is there to plug various very specific tubes to facilitate the DCVax-L process, regulate the environment, feed and keep the cells and facilitate various steps in the process, time things, etc. From my own experience and understanding of manufacturing, it would be expected that a much more robust process and facility would inevitably be developed by companies continuing to improve manufacturing processes to improve safety, reduce potential for human error and increase productivity. I think it is unlikely that the form of their ultimate factory, say in 5 years will remain exactly as indicated at this time. But I expect they may likely be bought long before then so that will be up to the acquirer. For now they just need to get Flaskworks Eden system into the factory and operating to achieve better scalability and a better price point.
News 
Market Data 
Discover 
